Barclays’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,278
| Closed | -$1K | – | 4708 |
|
|
2025
Q1 | $1K | Hold |
13,278
| – | – | ﹤0.01% | 4346 |
|
|
2024
Q4 | $10K | Hold |
13,278
| – | – | ﹤0.01% | 4189 |
|
|
2024
Q3 | $16K | Sell |
13,278
-179
| -1% | -$216 | ﹤0.01% | 4095 |
|
|
2024
Q2 | $27K | Sell |
13,457
-17,016
| -56% | -$34.1K | ﹤0.01% | 3850 |
|
|
2024
Q1 | $111K | Sell |
30,473
-16,500
| -35% | -$60.1K | ﹤0.01% | 3606 |
|
|
2023
Q4 | $142K | Buy |
46,973
+29,013
| +162% | +$87.7K | ﹤0.01% | 3624 |
|
|
2023
Q3 | $39K | Sell |
17,960
-203
| -1% | -$441 | ﹤0.01% | 3698 |
|
|
2023
Q2 | $101K | Sell |
18,163
-3,485
| -16% | -$19.4K | ﹤0.01% | 3399 |
|
|
2023
Q1 | $131K | Buy |
21,648
+328
| +2% | +$1.99K | ﹤0.01% | 3390 |
|
|
2022
Q4 | $122K | Buy |
21,320
+7,324
| +52% | +$41.9K | ﹤0.01% | 3358 |
|
|
2022
Q3 | $76K | Buy |
13,996
+718
| +5% | +$3.9K | ﹤0.01% | 3516 |
|
|
2022
Q2 | $50K | Sell |
13,278
-3,717
| -22% | -$14K | ﹤0.01% | 3727 |
|
|
2022
Q1 | $106K | Buy |
+16,995
| New | +$106K | ﹤0.01% | 3641 |
|